NCT00591149 - Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Head and Neck CancerCarcinoma, Squamous

Interventions

DRUG

Oxaliplatin

130 MG/M2 IV over 2 hours on day 1 of 21 day cycle over a period of 4 cycles

DRUG

Docetaxel

60 MG/M2 IV over 1 hour on day 1 of a 21 day cycle for a period of 4 cycles

DRUG

Cetuximab

400 MG/M2 on week 1 then 250 MG/M2 weekly for a total of 12 weeks

Trial Locations (1)

University of Kansas Medical Center, Kansas City